| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $536.9M | +19.1% |
| Cost of Revenue | $182.1M | +18.9% |
| Gross Profit | $354.8M | +19.2% |
| R&D Expense | $53.7M | +17.3% |
| SG&A Expense | $84.9M | +26.1% |
| Operating Income | $77.2M | +8.5% |
| Pre-tax Income | $85.6M | +20.0% |
| Income Tax | $19.7M | +21.9% |
| Net Income | $65.8M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $219.1M | +34.5% |
| Short-term Investments | $56.4M | +9.6% |
| Accounts Receivable | $46.8M | +18.8% |
| Current Assets | $401.4M | +24.4% |
| Total Assets | $823.8M | +22.4% |
| Current Liabilities | $130.7M | +18.1% |
| Total Liabilities | $156.4M | +15.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $132.3M | +32.2% |
| Capital Expenditures | $19.8M | -0.6% |
| Investing Cash Flow | -$92.6M | +17.9% |
| Financing Cash Flow | $16.0M | +150.5% |
| Free Cash Flow | $112.5M | +40.4% |
| +19.4% |
| EPS (Basic) | $1.80 | +17.6% |
| EPS (Diluted) | $1.76 | +18.1% |
| Stockholders' Equity |
| $667.5M |
| +24.3% |